DCM
RVMD icon

Driehaus Capital Management’s Revolution Medicines RVMD Stock Holding History

Driehaus Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-218,153
Closed -$6.04M – 448
2023
Q3 		$6.04M Sell
218,153
-490
-0.2% -$14.5K 0.08% 269
2023
Q2 		$5.85M Buy
218,643
+7,875
+4% +$193K 0.07% 263
2023
Q1 		$4.57M Sell
210,768
-5,539
-3% -$136K 0.06% 301
2022
Q4 		$5.15M Sell
216,307
-2,890
-1% -$61.4K 0.08% 263
2022
Q3 		$4.32M Buy
+219,197
New +$4.82M 0.07% 282
2021
Q2 		– Sell
-205,788
Closed -$9.44M – 510
2021
Q1 		$9.44M Buy
+205,788
New +$9.23M 0.14% 214

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Driehaus Capital Management's RVMD Position: Q4 2023 in Review

Driehaus Capital Management sold out of Revolution Medicines (RVMD) in Q4 2023, closing a stake of 218,153 shares — an estimated $6.04M sold.

Driehaus Capital Management first reported a position in RVMD in Q1 2021 and held it in 6 quarters. The position peaked at $9.44M in Q1 2021. 184 funds tracked by Wall St. Rank hold RVMD as of Q4 2023.

  • Driehaus Capital Management reported no remaining Revolution Medicines position as of Q4 2023 after selling out during the quarter.
  • Driehaus Capital Management sold 218,153 Revolution Medicines shares in Q4 2023, an estimated $6.04M.
  • Driehaus Capital Management first reported a position in Revolution Medicines in Q1 2021 and held it in 6 quarters.
  • Driehaus Capital Management's Revolution Medicines position peaked at $9.44M in Q1 2021.
  • 184 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2023.

Based on Driehaus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.